Role of chemical stimulation of the duodenum in dyspeptic symptom generation

American Journal of Gastroenterology

Volumn 105, Issue 4, 2010, Pages 803-811

  Van Boxel, O S ^a   Ter Linde, J J M ^a   Siersema, P D ^a   Smout, A J P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; CHOLECYSTOKININ; LIPID; MESSENGER RNA;

BIOSYNTHESIS; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DUODENUM PH; DYSPEPSIA; HUMAN; HYPERSENSITIVITY; IMMUNOCOMPETENT CELL; NUTRIENT CONCENTRATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SENSORIMOTOR FUNCTION; SENSORY NERVE; STIMULUS RESPONSE; STOMACH ACID SECRETION;

CAPSAICIN; DIETARY CARBOHYDRATES; DUODENUM; DYSPEPSIA; GASTRIC ACID; HUMANS; LIPIDS;

EID: 77950518233     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.100     Document Type: Review

References (149)

1. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004; 19: 643-654
2. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130: 1466-1479
3. Talley NJ. Functional gastrointestinal disorders in 2007 and Rome III: something new, something borrowed, something objective. Rev Gastroenterol Disord 2007; 7: 97-105.
4. Troncon LE, Bennett RJ, Ahluwalia NK et al. Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients. Gut 1994; 35: 327-332
5. Boeckxstaens GE, Hirsch DP, Kuiken SD et al. The proximal stomach and postprandial symptoms in functional dyspeptics. Am J Gastroenterol 2002; 97: 40-48
6. Tack J, Caenepeel P, Fischler B et al. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-535
7. De Schepper HU, Cremonini F, Chitkara D et al. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 2004; 16: 275-285
8. Tack J, Broeckaert D, Coulie B et al. The infl uence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther 1998; 12: 761-766
9. Thumshirn M, Camilleri M, Choi MG et al. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999; 116: 573-585
10. Bredenoord AJ, Chial HJ, Camilleri M et al. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol 2003; 1: 264-272
11. Kim DY, gado-Aros S, Camilleri M et al. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol 2001; 96: 3099-3105
12. Malagelada JR, Stanghellini V. Manometric evaluation of functional upper gut symptoms. Gastroenterology 1985; 88: 1223-1231
13. Barbera R, Feinle C, Read NW. Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia. Eur J Gastroenterol Hepatol 1995; 7: 1051-1057
14. Moayyedi P, Soo S, Deeks J et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005, CD002096.
15. Vandenberghe J, Dupont P, Van OL et al. Regional cerebral blood fl ow during gastric balloon distention in functional dyspepsia. Gastroenterology 2007; 132: 1684-1693
16. gado-Aros S, Camilleri M, Cremonini F et al. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004; 127: 1685-1694
17. Tack J, Piessevaux H, Coulie B et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 1346-1352
18. Sarnelli G, Caenepeel P, Geypens B et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003; 98: 783-788
19. van Lelyveld N, Scheff er R, Mundt M et al. Partial gastric volumes and upper abdominal sensations in functional dyspeptic and GERD patients: a 3D ultrasonographic study. Am J Gastroenterol 2006; 101: 1845-1852
20. van Lelyveld N, Schipper M, Samsom M. Lack of relationship between chronic upper abdominal symptoms and gastric function in functional dyspepsia. Dig Dis Sci 2008; 53: 1223-1230
21. Talley NJ, Meineche-Schmidt V, Pare P et al. Effi cacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 1055-1065
22. Redstone HA, Barrowman N, Veldhuyzen Van Zanten SJ. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a metaanalysis of randomized controlled clinical trials. Aliment Pharmacol Ther 2001; 15: 1291-1299
23. Talley NJ, Lauritsen K. The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies. Gut 2002; 50 (Suppl 4): iv36-41.
24. Bolling-Sternevald E, Lauritsen K, Aalykke C et al. Eff ect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebocontrolled trial. Scand J Gastroenterol 2002; 37: 1395-1402
25. Meineche-Schmidt V, Talley NJ, Pap A et al. Impact of functional dyspepsia on quality of life and health care consumption aft er cessation of antisecretory treatment. A multicentre 3-month follow-up study. Scand J Gastroenterol 1999; 34: 566-574
26. Conchillo JM, Selimah M, Bredenoord AJ et al. Air swallowing, belching, acid and non-acid refl ux in patients with functional dyspepsia. Aliment Pharmacol Ther 2007; 25: 965-971
27. Collen MJ, Loebenberg MJ. Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis. Dig Dis Sci 1989; 34: 246-250
28. Tack J, Caenepeel P, Arts J et al. Prevalence of acid refl ux in functional dyspepsia and its association with symptom profi le. Gut 2005; 54: 1370-1376
29. George AA, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 1991; 101: 3-6.
30. di Stefano M, Vos R, Vanuytsel T et al. Prolonged duodenal acid perfusion and dyspeptic symptom occurrence in healthy volunteers. Neurogastroenterol Motil 2009; 21: 712-e40.
31. Bratten J, Jones MP. Prolonged recording of duodenal acid exposure in patients with functional dyspepsia and controls using a radiotelemetry pH monitoring system. J Clin Gastroenterol 2009; 43: 527-533
32. Samsom M, Verhagen MA, vanBerge Henegouwen GP et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116: 515-520
33. Schwartz MP, Samsom M, Van Berge Henegouwen GP et al. Eff ect of inhibition of gastric acid secretion on antropyloroduodenal motor activity and duodenal acid hypersensitivity in functional dyspepsia. Aliment Pharmacol Ther 2001; 15: 1921-1928
34. Schwartz MP, Samsom M, Smout AJ. Human duodenal motor activity in response to acid and diff erent nutrients. Dig Dis Sci 2001; 46: 1472-1481
35. Schwartz MP, Samsom M, Smout AJ. Chemospecifi c alterations in duodenal perception and motor response in functional dyspepsia. Am J Gastroenterol 2001; 96: 2596-2602
36. Lee KJ, Vos R, Janssens J, Tack J. Infl uence of duodenal acidifi cation on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol 2004; 286: G278-84.
37. Simren M, Vos R, Janssens J, Tack J. Acid infusion enhances duodenal mechanosensitivity in healthy subjects. Am J Physiol Gastrointest Liver Physiol 2003; 285: G309-15.
38. Lee KJ, Kim JH, Cho SW. Dyspeptic symptoms associated with hypersensitivity to gastric distension induced by duodenal acidifi cation. J Gastroenterol Hepatol 2006; 21: 515-520
39. Woodtli W, Owyang C. Duodenal pH governs interdigestive motility in humans. Am J Physiol 1995; 268: G146-52.
40. Houghton LA, Read NW, Heddle R et al. Relationship between fl uctuations of pH and pressure in the human stomach and duodenum. Dig Dis 1990; 8 (Suppl 1): 71-81.
41. Hunt JN, Knox MT. The slowing of gastric emptying by four strong acids and three weak acids. J Physiol 1972; 222: 187-208.
42. Kellum Jr JM, Jaff e BM. Release of immunoreactive serotonin following acid perfusion of the duodenum. Ann Surg 1976; 184: 633-636
43. Lee KJ, Demarchi B, Demedts I et al. A pilot study on duodenal acid exposure and its relationship to symptoms in functional dyspepsia with prominent nausea. Am J Gastroenterol 2004; 99: 1765-1773
44. Rezek M, Novin D. Duodenal nutrient infusion: eff ects on feeding in intact and vagotomized rabbits. J Nutr 1976; 106: 812-820
45. Stephens DB. The effects of alimentary infusions of glucose, amino acids, or neutral fat on meal size in hungry pigs. J Physiol 1980; 299: 453-463
46. Gregory PC, Rayner DV. The infl uence of gastrointestinal infusion of fats on regulation of food intake in pigs. J Physiol 1987; 385: 471-481
47. Gregory PC, McFadyen M, Rayner DV. Control of gastric emptying in the pig: infl uence of duodenal infusions of glucose and emulsifi ed fat. Q J Exp Physiol 1989; 74: 109-119
48. Raybould HE. Capsaicin-sensitive vagal aff erents and CCK in inhibition of gastric motor function induced by intestinal nutrients. Peptides 1991; 12: 1279-1283
49. Raybould HE, Holzer H. Dual capsaicin-sensitive aff erent pathways mediate inhibition of gastric emptying in rat induced by intestinal carbohydrate. Neurosci Lett 1992; 141: 236-238
50. Lavin JH, Wittert G, Sun WM et al. Appetite regulation by carbohydrate: role of blood glucose and gastrointestinal hormones. Am J Physiol 1996; 271: E209-14.
51. Caldarella MP, Azpiroz F, Malagelada JR. Selective eff ects of nutrients on gut sensitivity and refl exes. Gut 2007; 56: 37-42.
52. Raybould HE, Glatzle J, Robin C et al. Expression of 5-HT3 receptors by extrinsic duodenal aff erents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 2003; 284: G367-72.
53. Reidelberger RD, Heimann D, Kelsey L et al. Eff ects of peripheral CCK receptor blockade on feeding responses to duodenal nutrient infusions in rats. Am J Physiol Regul Integr Comp Physiol 2003; 284: R389-98.
54. Rayner CK, Park HS, Wishart JM et al. Eff ects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans. Am J Physiol Regul Integr Comp Physiol 2000; 278: R360-6.
55. Feinle C, Grundy D, Read NW. Eff ects of duodenal nutrients on sensory and motor responses of the human stomach to distension. Am J Physiol 1997; 273: G721-6.
56. Pilichiewicz AN, Chaikomin R, Brennan IM et al. Load-dependent eff ects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 2007; 293: E743-53.
57. Chaikomin R, Wu KL, Doran S et al. Eff ects of mid-jejunal compared to duodenal glucose infusion on peptide hormone release and appetite in healthy men. Regul Pept 2008; 150: 38-42.
58. Chaikomin R, Jones KL, Feinle-Bisset C et al. Eff ects of intraluminal local anesthetic on upper gastrointestinal motor, sensory, and peptide hormone responses to intraduodenal glucose. Eur J Gastroenterol Hepatol 2009; 21: 258-265
59. Ladabaum U, Brown MB, Pan W et al. Eff ects of nutrients and serotonin 5-HT 3 antagonism on symptoms evoked by distal gastric distension in humans. Am J Physiol Gastrointest Liver Physiol 2001; 280: G201-8.
60. Carrasco M, Azpiroz F, Malagelada JR. Modulation of gastric accommodation by duodenal nutrients. World J Gastroenterol 2005; 11: 4848-4851
61. Barbera R, Feinle C, Read NW. Nutrient-specifi c modulation of gastric mechanosensitivity in patients with functional dyspepsia. Dig Dis Sci 1995; 40: 1636-1641
62. Feinle C, Christen M, Grundy D et al. Eff ects of duodenal fat, protein or mixed-nutrient infusions on epigastric sensations during sustained gastric distension in healthy humans. Neurogastroenterol Motil 2002; 14: 205-213
63. Ewald CO, Boas J. Bentrage zur Physiologic und Pathologic Derverlaung. Virchows Arch 1886;104:271-305.
64. Quigley JP, Zettelman HJ, Ivy AC. Analysis of the factors involved in gastric motor inhibition by fats. Am J Physiol 1934; 108: 643-651
65. Azpiroz F, Malagelada JR. Intestinal control of gastric tone. Am J Physiol 1985; 249: G501-9.
66. Azpiroz F, Malagelada JR. Vagally mediated gastric relaxation induced by intestinal nutrients in the dog. Am J Physiol 1986; 251: G727-35.
67. Bjornsson E, Sjoberg J, Ringstrom G et al. Eff ects of duodenal lipids on gastric sensitivity and relaxation in patients with ulcer-like and dysmotilitylike dyspepsia. Digestion 2003; 67: 209-217
68. Heddle R, Collins PJ, Dent J et al. Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion. J Gastroenterol Hepatol 1989; 4: 437-447
69. Feinle C, Grundy D, Read NW. Fat increases vection-induced nausea independent of changes in gastric emptying. Physiol Behav 1995; 58: 1159-1165
70. Welch IM, Sepple CP, Read NW. Comparisons of the eff ects on satiety and eating behaviour of infusion of lipid into the diff erent regions of the small intestine. Gut 1988; 29: 306-311
71. Chapman IM, Goble EA, Wittert GA et al. Eff ects of small-intestinal fat and carbohydrate infusions on appetite and food intake in obese and nonobese men. Am J Clin Nutr 1999; 69: 6-12.
72. Feinle C, Grundy D, Fried M. Modulation of gastric distension-induced sensations by small intestinal receptors. Am J Physiol Gastrointest Liver Physiol 2001; 280: G51-7.
73. Feinle C, Meier O, Otto B et al. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001; 48: 347-355
74. Houghton LA, Mangnall YF, Dwivedi A et al. Sensitivity to nutrients in patients with non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 1993; 5: 109-113
75. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007; 117: 13-23.
76. Polak JM, Bloom SR, Rayford PL et al. Identifi cation of cholecystokinin-secreting cells. Lancet 1975; 2: 1016-1018
77. Richards W, Hillsley K, Eastwood C et al. Sensitivity of vagal mucosal afferents to cholecystokinin and its role in aff erent signal transduction in the rat. J Physiol 1996; 497 (Part 2): 473-481
78. Lal S, Kirkup AJ, Brunsden AM et al. Vagal aff erent responses to fatty acids of diff erent chain length in the rat. Am J Physiol Gastrointest Liver Physiol 2001; 281: G907-15.
79. Blackshaw LA, Grundy D. Eff ects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal aff erent fi bre. J Auton Nerv Syst 1990; 31: 191-201.
80. Blackshaw LA, Grundy D. Locally and refl exly mediated eff ects of cholecystokinin-octapeptide on the ferret stomach. J Auton Nerv Syst 1991; 36: 129-137
81. Raybould HE, Zittel TT, Holzer HH et al. Gastroduodenal sensory mechanisms and CCK in inhibition of gastric emptying in response to a meal. Dig Dis Sci 1994; 39: 41S-3S.
82. Gibbs J, Maddison SP, Rolls ET. Satiety role of the small intestine examined in sham-feeding rhesus monkeys. J Comp Physiol Psychol 1981; 95: 1003-1015
83. Lieverse RJ, Jansen JB, Masclee AM et al. Satiety eff ects of cholecystokinin in humans. Gastroenterology 1994; 106: 1451-1454
84. Miaskiewicz SL, Stricker EM, Verbalis JG. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distention in humans. J Clin Endocrinol Metab 1989; 68: 837-843
85. Feinle C, Grundy D, Otto B et al. Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1217-23.
86. Verbalis JG, Richardson DW, Stricker EM. Vasopressin release in response to nausea-producing agents and cholecystokinin in monkeys. Am J Physiol 1987; 252: R749-53.
87. Lieverse RJ, Jansen JB, Masclee AA et al. Satiety eff ects of a physiological dose of cholecystokinin in humans. Gut 1995; 36: 176-179
88. Fried M, Erlacher U, Schwizer W et al. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology 1991; 101: 503-511
89. Holzer HH, Turkelson CM, Solomon TE et al. Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive aff erent pathway in rats. Am J Physiol 1994; 267: G625-9.
90. Lieverse RJ, Jansen JB, Masclee AA et al. Eff ect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide. Gut 1994; 35: 501-505
91. Borovicka J, Kreiss C, Asal K et al. Role of cholecystokinin as a regulator of solid and liquid gastric emptying in humans. Am J Physiol 1996; 271: G448-53.
92. Feinle C D, Amato M, Read NW. Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 1996; 110: 1379-1385
93. Schwizer W, Borovicka J, Kunz P et al. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut 1997; 41: 500-504
94. Kreiss C, Schwizer W, Borovicka J et al. Eff ect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans. Regul Pept 1998; 74: 143-149
95. Matzinger D, Gutzwiller JP, Drewe J et al. Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. Am J Physiol 1999; 277: R1718-24.
96. Lal S, McLaughlin J, Barlow J et al. Cholecystokinin pathways modulate sensations induced by gastric distension in humans. Am J Physiol Gastrointest Liver Physiol 2004; 287: G72-9.
97. Schwizer W, Asal K, Kreiss C et al. Role of lipase in the regulation of upper gastrointestinal function in humans. Am J Physiol 1997; 273: G612-20.
98. Borovicka J, Schwizer W, Guttmann G et al. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specifi c lipase inhibitor. Gut 2000; 46: 774-781
99. Degen L, Matzinger D, Drewe J et al. Role of free fatty acids in regulating gastric emptying and gallbladder contraction. Digestion 2006; 74: 131-139
100. Ellrichmann M, Kapelle M, Ritter PR et al. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations. J Clin Endocrinol Metab 2008; 93: 3995-3998
101. Feinle C, Rades T, Otto B et al. Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans. Gastroenterology 2001; 120: 1100-1107
102. Matzinger D, Degen L, Drewe J et al. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 2000; 46: 688-693
103. Feinle C, O ' Donovan D, Doran S et al. Eff ects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. Am J Physiol Gastrointest Liver Physiol 2003; 284: G798-807.
104. Hunt JN, Knox MT. A relation between the chain length of fatty acids and the slowing of gastric emptying. J Physiol 1968; 194: 327-336
105. Feltrin KL, Little TJ, Meyer JH et al. Eff ects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. Am J Physiol Regul Integr Comp Physiol 2004; 287: R524-33.
106. Meyer JH, Hlinka M, Tabrizi Y et al. Chemical specifi cities and intestinal distributions of nutrient-driven satiety. Am J Physiol 1998; 275: R1293-307.
107. Tso P, Balint JA. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol 1986; 250: G715-26.
108. McLaughlin J, Grazia LM, Jones MN et al. Fatty acid chain length determines cholecystokinin secretion and eff ect on human gastric motility. Gastroenterology 1999; 116: 46-53.
109. Raybould HE, Meyer JH, Tabrizi Y et al. Inhibition of gastric emptying in response to intestinal lipid is dependent on chylomicron formation. Am J Physiol 1998; 274: R1834-8.
110. Chua AS, Dinan TG, Rovati LC, Keeling PW. Cholecystokinin hyperresponsiveness in dysmotility-type nonulcer dyspepsia. Ann NY Acad Sci 1994; 713: 298-299
111. Chua AS, Bekkering M, Rovati LC, Keeling PW. Clinical effi cacy and prokinetic eff ect of the CCK-A antagonist loxiglumide in nonulcer dyspepsia. Ann NY Acad Sci 1994; 713: 451-453
112. Pilichiewicz AN, Feltrin KL, Horowitz M et al. Functional dyspepsia is associated with a greater symptomatic response to fat but not carbohydrate, increased fasting and postprandial CCK, and diminished PYY. Am J Gastroenterol 2008; 103: 2613-2623
113. French SJ, Murray B, Rumsey RD et al. Adaptation to high-fat diets: eff ects on eating behaviour and plasma cholecystokinin. Br J Nutr 1995; 73: 179-189
114. French SJ, Murray B, Rumsey RD et al. Preliminary studies on the gastrointestinal responses to fatty meals in obese people. Int J Obes Relat Metab Disord 1993; 17: 295-300.
115. Hammer J, Hammer HF, Eherer AJ et al. Intraluminal capsaicin does not aff ect fl uid and electrolyte absorption in the human jejunum but does cause pain. Gut 1998; 43: 252-255
116. Schmidt B, Hammer J, Holzer P et al. Chemical nociception in the jejunum induced by capsaicin. Gut 2004; 53: 1109-1116
117. Hammer J, Vogelsang H. Characterization of sensations induced by capsaicin in the upper gastrointestinal tract. Neurogastroenterol Motil 2007; 19: 279-287
118. Corsetti M, Vos R, Janssens J et al. Eff ect of duodenal administration of capsaicin on sensorimotor function of the proximal stomach in man. Gastroenterology 2004; 126 (Suppl 2): A74.
119. Hammer J. Hyperalgesia against capsaicin in persons with un-investigated dyspepsia: potential as a new diagnostic test. Wien Klin Wochenschr 2006; 118: 43-48
120. Hammer J, Fuhrer M, Pipal L et al. Hypersensitivity for capsaicin in patients with functional dyspepsia. Neurogastroenterol Motil 2008; 20: 125-133
121. Caterina MJ, Schumacher MA, Tominaga M et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-824
122. Tominaga M, Caterina MJ, Malmberg AB et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998; 21: 531-543
123. Cortright DN, Crandall M, Sanchez JF et al. The tissue distribution and functional characterization of human VR1. Biochem Biophys Res Commun 2001; 281: 1183-1189
124. Smart D, Jerman JC, Gunthorpe MJ et al. Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur J Pharmacol 2001; 417: 51-58
125. Savidge J, Davis C, Shah K et al. Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology 2002; 43: 450-456
126. Gavva NR, Klionsky L, Qu Y et al. Molecular determinants of vanilloid sensitivity in TRPV1. J Biol Chem 2004; 279: 20283-20295
127. Trevisani M, Smart D, Gunthorpe MJ et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nat Neurosci 2002; 5: 546-551
128. Ward SM, Bayguinov J, Won KJ et al. Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J Comp Neurol 2003; 465: 121-135
129. Blackshaw LA, Page AJ, Partosoedarso ER. Acute eff ects of capsaicin on gastrointestinal vagal aff erents. Neuroscience 2000; 96: 407-416
130. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 159-212.
131. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991; 43: 143-201.
132. Bortolotti M, Coccia G, Grossi G et al. The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther 2002; 16: 1075-1082 (Pubitemid 34680749)
133. Bortolotti M, Coccia G, Grossi G. Red pepper and functional dyspepsia. N Engl J Med 2002; 346: 947-948
134. Gonlachanvit S, Fongkam P, Wittayalertpanya S et al. Red chili induces rectal hypersensitivity in healthy humans: possible role of 5HT-3 receptors on capsaicin-sensitive visceral nociceptive pathways. Aliment Pharmacol Ther 2007; 26: 617-625
135. Karamanolis G, Vos R, Janssens J et al. Involvement of a 5-HT 3 receptor in the capsaicin-induced inhibitory duodenogastric refl ex in man. Gastroenterology 2006; 130 (Suppl. 2): A250.
136. Hammer J, Fuhrer M. Intestinal chemo-and mechano-sensitivity: selective modifi cation of small intestinal sensitivity by lipids. Aliment Pharmacol Ther 2007; 26: 117-124
137. Fuhrer M, Hammer J. Duodenal chemosensitivity and mechanosensitivity in humans during acid and ethanol perfusion. Eur J Gastroenterol Hepatol 2008; 20: 537-544
138. Akiba Y, Guth PH, Engel E et al. Dynamic regulation of mucus gel thickness in rat duodenum. Am J Physiol Gastrointest Liver Physiol 2000; 279: G437-47.
139. Talley NJ, Walker MM, Aro P et al. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007; 5: 1175-1183
140. Friesen CA, Kearns GL, Andre L et al. Clinical effi cacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr 2004; 38: 343-351
141. Tack J, Demedts I, Dehondt G et al. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002; 122: 1738-1747
142. Kindt S, Tertychnyy A, de HG, Geboes K, Tack J. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 2009; 21: 832-e56.
143. Aerssens J, Hillsley K, Peeters PJ et al. Alterations in the brain-gut axis underlying visceral chemosensitivity in Nippostrongylus brasiliensis-infected mice. Gastroenterology 2007; 132: 1375-1387
144. Beyak MJ, Vanner S. Infl ammation-induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage-gated ion channels. Neurogastroenterol Motil 2005; 17: 175-186
145. Wheatcroft J, Wakelin D, Smith A et al. Enterochromaffi n cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 2005; 17: 863-870
146. van Lelyveld N, ter Linde J, Schipper M et al. Serotonergic signalling in the stomach and duodenum of patients with gastroparesis. Neurogastroenterol Motil 2008; 20: 448-455
147. Foxx-Orenstein AE, Camilleri MC, Gershon MD et al. Alterations in intestinal serotonin expression in dyspepsia and irritable bowel syndrome. Gastroenterology 2007; 132 (Suppl 2): A72.
148. Chan CL, Facer P, Davis JB et al. Sensory fi bres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2003; 361: 385-391
149. Akbar A, Yiangou Y, Facer P et al. Increased capsaicin receptor TRPV1-expressing sensory fi bres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008; 57: 923-929